PT. Penta Valent Tbk (IDX:PEVE)

Revenue by Segment

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Pharmaceutical Product	2.87T	2.53T	2.15T	1.93T	1.58T
Pharmaceutical Product Growth	13.51%	17.64%	11.12%	21.99%	27.96%
Consumer Product	679.29B	485.37B	336.21B	213.90B	203.08B
Consumer Product Growth	39.95%	44.36%	57.19%	5.32%	42.95%
Total	3.55T	3.01T	2.48T	2.15T	1.79T
Total Growth	17.77%	21.25%	15.71%	20.10%	29.50%

Revenue by Geography

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Indonesia	3.55T	3.01T	2.48T	2.15T	1.79T
Indonesia Growth	17.77%	21.25%	15.71%	20.10%	29.50%
Total	3.55T	3.01T	2.48T	2.15T	1.79T
Total Growth	17.77%	21.25%	15.71%	20.10%	29.50%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 12, 2026

Data Sources Report a data error